机构:[1]State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China[2]Department of Thoracic Surgery, Guangzhou Institute of Respiratory Health and State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, China[3]Department of Oncology, Kiang Wu Hospital, Macau, SAR, China
Science and Technology Development Fund, Macau SAR (file no: 0096/2018/A3, 130/2017/A3, 0099/2018/A3) and the NSFC overseas and Hong Kong and Macao Scholars Cooperative Research Fund Project (Project no: 81828013).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类|2 区医学
小类|2 区药学
最新[2025]版:
大类|3 区医学
小类|3 区药学
第一作者:
第一作者机构:[1]State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China
通讯作者:
通讯机构:[1]State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, SAR, China[2]Department of Thoracic Surgery, Guangzhou Institute of Respiratory Health and State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, China
推荐引用方式(GB/T 7714):
Huang Jumin,Jiang Zebo,Wang Yuwei,et al.Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.[J].Current opinion in pharmacology.2020,54:1-10.doi:10.1016/j.coph.2020.06.004.
APA:
Huang Jumin,Jiang Zebo,Wang Yuwei,Fan Xiaoqing,Cai Jun...&Leung Elaine Lai-Han.(2020).Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy..Current opinion in pharmacology,54,
MLA:
Huang Jumin,et al."Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.".Current opinion in pharmacology 54.(2020):1-10